Kelly Huffaker
Psychiatric/Mental Health · Chandler, AZNPI 1326682790
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 270 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,656 and has fallen 88.6% since, to $189 in 2025. Among psychiatric/mental health clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 270 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$645
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$426
- Corium, LLC$413
- Ironshore Pharmaceuticals Inc.$367
- Johnson & Johnson$358
- plus $2K from 20 others
What the payments were for
- Consulting fees$1152%
- Food & beverage$4,78797%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 76 | $1,043 |
| Otsuka America Pharmaceutical, Inc. | 25 | $645 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $426 |
| Corium, LLC | 20 | $413 |
| Ironshore Pharmaceuticals Inc. | 19 | $367 |
| Johnson & Johnson | 12 | $358 |
| Sunovion Pharmaceuticals Inc. | 19 | $337 |
| Axsome Therapeutics, Inc. | 13 | $192 |
| Alkermes, Inc. | 9 | $187 |
| Vanda Pharmaceuticals Inc. | 10 | $169 |
| Almatica Pharma LLC | 6 | $123 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| Tris Pharma Inc | 6 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $89 |
| Teva Pharmaceuticals USA, Inc. | 4 | $85 |
| Lundbeck LLC | 3 | $60 |
| Noven Therapeutics, LLC | 3 | $45 |
| Merck | 2 | $35 |
| Neurocrine Biosciences, Inc. | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $18 |
| Bausch Health US, LLC | 1 | $17 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Neos Therapeutics, LP | 1 | $14 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ABILIFY MAINTENA$245
- Azstarys$125
- SPRAVATO$115
How this compares
$4,949 in reported general payments places this provider in the 90th percentile of 1,230 psychiatric/mental health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Escitalopram Oxalate | 12 | $52 |
| Gabapentin | 11 | $28 |
| Zolpidem Tartrate | 12 | $21 |
| Alprazolam | 12 | $12 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Chandler
- Amanda FitzgeraldChandler$10K
- Ruth FluckerChandler$6K
- Devin SouthworthChandler$5K
- Elizabeth ElliottPhoenix$363K
- Diane StrickerGilbert$281K
- Russell HorningPhoenix$254K
- Stacy UnderwoodMesa$252K
- Brett LeifsonScottsdale$90K
- Claire ReecePhoenix$88K
- Bryan LazaroScottsdale$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.